Overview
Robert Thompson is an Oncologist in Rochester, Minnesota. Dr. Thompson is highly rated in 22 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Bladder Cancer, Nephrectomy, and Cystectomy.
His clinical research consists of co-authoring 288 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
200 1st St SW, Rochester, MN 55905
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MN - Cancer
Stephen Ansell is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Ansell is highly rated in 26 conditions, according to our data. His top areas of expertise are Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Tissue Biopsy.
MN - Cancer Transplant
Francis Buadi is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Buadi is highly rated in 13 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Primary Amyloidosis, Smoldering Multiple Myeloma, POEMS Syndrome, and Bone Marrow Transplant.
MN - Cancer Transplant
Prashant Kapoor is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Kapoor is highly rated in 18 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Waldenstrom Macroglobulinemia, Primary Amyloidosis, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant.
Frequently Asked Questions about Dr. Robert Thompson
How do I make an appointment with Dr. Robert Thompson?
You can book an appointment with Dr. Robert Thompson by calling their office at 507-538-5363. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Robert Thompson a top-rated expert for Renal Cell Carcinoma (RCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robert Thompson is classified as an Elite expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Robert Thompson specialize in?
While Dr. Robert Thompson is a Oncology, they have specific expertise in Renal Cell Carcinoma (RCC), Nephrectomy, and Cystectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Robert Thompson participate in research or clinical trials?
Yes. Dr. Robert Thompson has published 288 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Dr. Robert Thompson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Robert Thompson accept my insurance?
Dr. Robert Thompson accepts most major insurance plans, including Change Healthcare and Cigna. We recommend calling the office directly at 507-538-5363 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bladder CancerDr. Thompson isElite. Learn about Bladder Cancer.
- Chromophobe Renal Cell Carcinoma
- CystectomyDr. Thompson isElite. Learn about Cystectomy.
- NephrectomyDr. Thompson isElite. Learn about Nephrectomy.
- Renal Cell Carcinoma (RCC)Dr. Thompson isElite. Learn about Renal Cell Carcinoma (RCC).
- Distinguished
- Familial Prostate CancerDr. Thompson isDistinguished. Learn about Familial Prostate Cancer.
- Muscle Invasive Bladder CancerDr. Thompson isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Prostate CancerDr. Thompson isDistinguished. Learn about Prostate Cancer.
- ProstatectomyDr. Thompson isDistinguished. Learn about Prostatectomy.
- Renal OncocytomaDr. Thompson isDistinguished. Learn about Renal Oncocytoma.
- Urothelial CancerDr. Thompson isDistinguished. Learn about Urothelial Cancer.
- Advanced
- Clear Cell SarcomaDr. Thompson isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Thompson isAdvanced. Learn about Familial Wilms Tumor 2.
- Horseshoe KidneyDr. Thompson isAdvanced. Learn about Horseshoe Kidney.
- Non-Muscle Invasive Bladder CancerDr. Thompson isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Reconstructive Urology SurgeryDr. Thompson isAdvanced. Learn about Reconstructive Urology Surgery.
- ThrombectomyDr. Thompson isAdvanced. Learn about Thrombectomy.
- Experienced
- Bilateral HydronephrosisDr. Thompson isExperienced. Learn about Bilateral Hydronephrosis.
- BoilsDr. Thompson isExperienced. Learn about Boils.
- CarbuncleDr. Thompson isExperienced. Learn about Carbuncle.
- EmpyemaDr. Thompson isExperienced. Learn about Empyema.
- End-Stage Renal Disease (ESRD)Dr. Thompson isExperienced. Learn about End-Stage Renal Disease (ESRD).
- EndoscopyDr. Thompson isExperienced. Learn about Endoscopy.
